NCT02054299View on ClinicalTrials.gov

Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Drug MetabolismMembrane Transport
Interventions
DRUG

Drug application Amitriptyline

Amitriptyline: 25 mg, single oral application

DRUG

Drug application Desvenlafaxine

Desvenlafaxine: 50 mg, single oral application

DRUG

Drug application Sumatriptan

Sumatriptan: 50 mg, single oral application

DRUG

Drug application Proguanil

Proguanil: 200mg, single oral application

DRUG

Drug application Fenoterol

Fenoterol: 180 mcg, single intravenous application

DRUG

Drug application Thiamine

Thiamine: 200mg, single oral application

Trial Locations (1)

37075

Department of Clinical Pharmacology, University Medical Center Goettingen, Göttingen

All Listed Sponsors
lead

University Medical Center Goettingen

OTHER

NCT02054299 - Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1 | Biotech Hunter | Biotech Hunter